Selection and evolution of high-affinity human anti-viral antibodies

Trends in Biotechnology

Volumn 14, Issue 7, 1996, Pages 230-234

  Barbas III, Carlos F ^a   Burton, Dennis R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; PRIORITY JOURNAL;

EID: 0030200088     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-7799(96)10029-9     Document Type: Note

References (26)

1. 1 Chanock, R. M., Crowe, J. E., Jr, Murphy, B. R. and Burton, D. R. (1993) Infect. Agents Dis. 2, 118-131
2. 2 Burton, D. R., Barbas, C. F., III, Persson, M. A., Koenig, S., Chanock, R. M. and Lerner, R. A. (1991) Proc. Natl Acad. Sci. USA 88, 10134-10137
3. 3 Barbas, C. F., III et al. (1992) Proc. Natl Acad. Sci. USA 89, 9339-9343
4. 4 Burton, D. R. et al. (1994) Science 266, 1024-1027
5. 5 Moore, J. P. et al. (1995) J. Virol. 69, 101-109
6. 6 Barbas, C. F., III et al. (1992) Proc. Natl Acad. Sci. USA 89, 10164-10168
7. 7 Crowe, J. E. Jr, Murphy, B. R., Chanock, R. M., Williamson, R. A., Barbas, C. F., III and Burton, D. R. (1994) Proc. Natl Acad. Sci. USA 91, 1386-1390
8. 8 Williamson, R. A. J., Burioni, R., Sanna, P. P., Partridge, L. J., Barbas, C. F., III and Burton, D. R. (1993) Proc. Natl Acad. Sci. USA 90, 4141-4145
9. 9 Burioni, R., Williamson, R. A., Sanna, P. P., Bloom, F. E. and Burton, D. R. (1994) Proc. Natl Acad. Sci. USA 91, 355-359
10. 10 Sanna, P. P. et al. (1996) Virology 215, 101-106
11. 11 Ditzel, H. J. et al. (1995) J. Immunol. 154, 895-908
12. 12 Burton, D. R. (1995) in Vaccines 95; Molecular Approaches to the Control of Infectious Diseases (Chanock, R. M., Brown, F., Ginsberg, H. S. and Norrby, E., eds), pp. 1-11, Cold Spring Harbor Laboratory Press
13. 13 Parren, P. W. H. I. et al. (1995) Aids 9, F1-F6
14. 14 Gauduin, M-C., Allaway, G. P., Maddon, P. J., Barbas, C. F., III., Burton, D. R. and Koup, R. A. J. Cell. Biochem. (in press)
15. 15 Tsui, P. et al. in Vaccines 96; Molecular Approaches to the Control of Infectious Diseases (Brown, F., Burton, D. R., Mekalanos, J. and Norrby, E., eds), Cold Spring Harbor Laboratory Press (in press)
16. 16 Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., III and Burton, D. R. (1994) J. Virol. 68, 4821-4828
17. 17 Sattentau, Q. J. and Moore, J. P. (1995) J. Exp. Med. 182, 185-196
18. 18 Winter, G., Griffiths, A. D., Hawkins, R. E. and Hoogenboom, H. R. (1994) Annu. Rev. Immunol. 12, 433-455
19. 19 Burton, D. R. and Barbas, C. F., III (1994) Adv. Immunol. 57, 191-280
20. 20 Barbas, C. F., III, Bain, J. D., Hoekstra, D. M. and Lerner, R. A. (1992) Proc. Natl Acad. Sci. USA 89, 4457-4461
21. 21 Barbas, C. F., III et al. (1994) Proc. Natl Acad. Sci. USA 91, 3809-3813
22. 22 Yang, W-P., Green, K., Pinz-Sweeney, S., Briones, A. T., Burton, D. R. and Barbas, C. F., III (1995) J. Mol. Biol. 254, 392-403
23. 23 Wilson, I. A. and Stanfield, R. L. (1993) Curr. Opin. Struct. Biol. 3, 113-118
24. 24 Wells, J. A. (1993) Biochemistry 3, 113-118
25. 25 Wagner, J., Lerner, R. A. and Barbas, C. F., III (1995) Science 270, 1797-1800
26. 26 Jackson, J. R., Sathe, G., Rosenberg, M. and Sweet, R. (1995) J. Immunol. 154, 3310-3319